2024年5月17日，歐盟食品安全局（EFSA）就審查γ-氟氯氰菌酯（gamma-cyhalothrin）的現有最大殘留水平發布意見。
根據歐盟委員會第396/2005號法規第12章，歐盟食品安全局對γ-氟氯氰菌酯的最大殘留限量進行了審查。根據現有數據，預計第396/2005號條例（歐盟委員會）目前設定的最大殘留限量將涵蓋本次審查中評估的γ-氯氟氰菊酯的用途。因此，風險管理者可以考慮維持現有的歐盟最大殘留限量。部分原文報道如下：
According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance gamma-cyhalothrin. To assess the occurrence of gamma-cyhalothrin residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011, as well as the European authorisations reported by Member States (including the supporting residues data) in the framework of this review. based on the assessment of the available data, MRL proposals were derived, and a consumer risk assessment was carried out. Although no risk to consumers was identified, some information required by the regulatory framework was missing. The residue definition for monitoring (lambda-cyhalothrin (includes gamma-cyhalothrin) (sum of R, S and S, R isomers)) covers both lambda- and gamma-cyhalothrin. Appropriate enantioselective techniques, which are not commonly used in routine analysis, are required to differentiate gamma-cyhalothrin residues from lambda-cyhalothrin. According to the available data, it is expected that the MRLs currently set in Regulation (EC) No 396/2005 will cover the uses of gamma-cyhalothrin assessed in the present review. Therefore, risk managers can consider maintaining the existing EU MRLs.
根據歐盟委員會第396/2005號法規第12章，歐盟食品安全局對γ-氟氯氰菌酯的最大殘留限量進行了審查。根據現有數據，預計第396/2005號條例（歐盟委員會）目前設定的最大殘留限量將涵蓋本次審查中評估的γ-氯氟氰菊酯的用途。因此，風險管理者可以考慮維持現有的歐盟最大殘留限量。部分原文報道如下：
According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance gamma-cyhalothrin. To assess the occurrence of gamma-cyhalothrin residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011, as well as the European authorisations reported by Member States (including the supporting residues data) in the framework of this review. based on the assessment of the available data, MRL proposals were derived, and a consumer risk assessment was carried out. Although no risk to consumers was identified, some information required by the regulatory framework was missing. The residue definition for monitoring (lambda-cyhalothrin (includes gamma-cyhalothrin) (sum of R, S and S, R isomers)) covers both lambda- and gamma-cyhalothrin. Appropriate enantioselective techniques, which are not commonly used in routine analysis, are required to differentiate gamma-cyhalothrin residues from lambda-cyhalothrin. According to the available data, it is expected that the MRLs currently set in Regulation (EC) No 396/2005 will cover the uses of gamma-cyhalothrin assessed in the present review. Therefore, risk managers can consider maintaining the existing EU MRLs.
